These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30555351)

  • 1. Semaphorin 7A Promotes VEGFA/VEGFR2-Mediated Angiogenesis and Intraplaque Neovascularization in
    Hu S; Liu Y; You T; Zhu L
    Front Physiol; 2018; 9():1718. PubMed ID: 30555351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Semaphorin 7A Upregulation by Disturbed Flow Promotes Atherosclerosis Through Endothelial β1 Integrin.
    Hu S; Liu Y; You T; Heath J; Xu L; Zheng X; Wang A; Wang Y; Li F; Yang F; Cao Y; Zhang H; van Gils JM; van Zonneveld AJ; Jo H; Wu Q; Zhang Y; Tang C; Zhu L
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):335-343. PubMed ID: 29269512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin 7A knockdown improves injury and prevents endothelial-to-mesenchymal transition in ox-LDL-induced HUVECs by regulating β1 integrin expression.
    Song X; Meng J; Yan G; Wang H; Li H; Lou D
    Exp Ther Med; 2021 Dec; 22(6):1441. PubMed ID: 34721683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorin 7A promotes endothelial to mesenchymal transition through ATF3 mediated TGF-β2/Smad signaling.
    Hong L; Li F; Tang C; Li L; Sun L; Li X; Zhu L
    Cell Death Dis; 2020 Aug; 11(8):695. PubMed ID: 32826874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial semaphorin 7A promotes seawater aspiration-induced acute lung injury through plexin C1 and β1 integrin.
    Zhang M; Yan X; Liu W; Sun R; Xie Y; Jin F
    Mol Med Rep; 2017 Oct; 16(4):4215-4221. PubMed ID: 28765893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin 7A promotes endothelial permeability and inflammation via plexin C1 and integrin β1 in Kawasaki disease.
    Huang J; Zhao C; Zhang S
    BMC Pediatr; 2024 Apr; 24(1):285. PubMed ID: 38678170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin.
    Suzuki K; Okuno T; Yamamoto M; Pasterkamp RJ; Takegahara N; Takamatsu H; Kitao T; Takagi J; Rennert PD; Kolodkin AL; Kumanogoh A; Kikutani H
    Nature; 2007 Apr; 446(7136):680-4. PubMed ID: 17377534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semaphorin 7A interacts with nuclear factor NF-kappa-B p105 via integrin β1 and mediates inflammation.
    Li X; Xie W; Pan Q; Zhang X; Zhang L; Zhao N; Xie Q; Ding J; Chai J
    Cell Commun Signal; 2023 Jan; 21(1):24. PubMed ID: 36717921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells.
    Ghofrani J; Lucar O; Dugan H; Reeves RK; Jost S
    Eur J Immunol; 2019 Aug; 49(8):1153-1166. PubMed ID: 31016720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo.
    Fang Y; Yang R; Hou Y; Wang Y; Yang N; Xu M; Li S; Gao S; Jiang M; Fan J; Hu Y; Xu Z; Gao L; Cao F
    Mol Imaging Biol; 2022 Oct; 24(5):721-731. PubMed ID: 35604528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin 7A promotes angiogenesis in an experimental corneal neovascularization model.
    Ghanem RC; Han KY; Rojas J; Ozturk O; Kim DJ; Jain S; Chang JH; Azar DT
    Curr Eye Res; 2011 Nov; 36(11):989-96. PubMed ID: 21999225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis.
    Xie J; Wang H
    Arthritis Res Ther; 2017 Jan; 19(1):10. PubMed ID: 28109308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun N-terminal kinase mediated VEGFR2 sustained phosphorylation is critical for VEGFA-induced angiogenesis in vitro and in vivo.
    Shen K; Ji L; Lu B; Wang Z
    Cell Biochem Biophys; 2012 Sep; 64(1):17-27. PubMed ID: 22592917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
    Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
    Costa C; Martínez-Sáez E; Gutiérrez-Franco A; Eixarch H; Castro Z; Ortega-Aznar A; Ramón Y Cajal S; Montalban X; Espejo C
    Mult Scler; 2015 Nov; 21(13):1632-43. PubMed ID: 26432853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice.
    Van der Veken B; De Meyer GRY; Martinet W
    Vascul Pharmacol; 2018 Jan; 100():34-40. PubMed ID: 29079346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
    Wang J; Yang L; Liang F; Chen Y; Yang G
    J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant RGD-disintegrin DisBa-01 blocks integrin α
    Danilucci TM; Santos PK; Pachane BC; Pisani GFD; Lino RLB; Casali BC; Altei WF; Selistre-de-Araujo HS
    Cell Commun Signal; 2019 Mar; 17(1):27. PubMed ID: 30894182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound Microbubble Delivery Targeting Intraplaque Neovascularization Inhibits Atherosclerotic Plaque in an APOE-deficient Mouse Model.
    Yuan H; Hu H; Sun J; Shi M; Yu H; Li C; Sun YU; Yang Z; Hoffman RM
    In Vivo; 2018; 32(5):1025-1032. PubMed ID: 30150423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.